Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 12/20 | 0.43 |
| ▸ | CTSS | P25774 | 6/20 | 0.39 |
| ▸ | CTSK | P43235 | 6/20 | 0.39 |
| ▸ | CTSB | P07858 | 5/20 | 0.39 |
| ▸ | CTSC | P53634 | 2/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22455228 | 0.78 | CTSC (0.41) | CTSLCTSSCTSKCTSBCTSC | |
| SCHEMBL13401138 | 0.76 | CTSL (0.49) | CTSLCTSSCTSKCTSBCTSC | |
| SCHEMBL14944319 | 0.74 | CTSL (0.48) | CTSLCTSSCTSKCTSBCTSC | |
| SCHEMBL13684412 | 0.74 | MEN1 (0.57) | RXFP1KDM4EATM | |
| SCHEMBL21413355 | 0.73 | RXFP1 (0.45) | CTSLCTSSCTSKCTSBCTSC | |
| SCHEMBL13435738 | 0.73 | — | — | |
| SCHEMBL19116799 | 0.72 | CTSL (0.46) | CTSLCTSSCTSKCTSB | |
| SCHEMBL17034775 | 0.71 | EPHX2 (0.37) | — | |
| SCHEMBL11568932 | 0.70 | MEN1 (0.38) | CTSLCTSSCTSKCTSBRXFP1 | |
| SCHEMBL11562969 | 0.70 | CTSL (0.36) | CTSLCTSSCTSKCTSBCTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002364-A1 | BENZOTHIOPHENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002364-A1 | BENZOTHIOPHENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF | GPER1, GABRQ, GPR39 | CTSL 4362/4885CTSS 4494/4885CTSK 4724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.